相关实验视频

Updated: Sep 13, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

超越极限:MYC调解瘤免疫逃生

Zhongyang Hong¹, Sitong Ming¹, Xin Luan²

¹School of Pharmaceutical Science, Changchun University of Chinese Medicine, Changchun 130117, China.

Pharmaceuticals (Basel, Switzerland)

|July 30, 2025

概括

MYC,一个关键的癌症驱动器,促进瘤生长和免疫逃避. 这项研究探讨了新的MYC驱动的免疫逃生机制,并提出了针对MYC和免疫治疗的组合疗法,以加强癌症治疗.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

MYC是一种转录因子,在约70%的人类癌症中至关重要,驱动瘤进展和免疫逃避.
虽然MYC无活化导致瘤回归 (基因成),但体外研究显示细胞存活,这表明瘤微环境的作用.
尽管已知MYC的作用,但MYC在瘤免疫逃避中的精确机制尚未完全理解.

研究的目的:

研究MYC促进瘤免疫逃避的新机制.
探索基于这些机制的针对MYC和免疫治疗的联合治疗策略.
评估向MYC相互作用蛋白作为临床转化直接MYC抑制的替代方案.

主要方法:

探索MYC介导的新型免疫逃避途径.
调查MYC在调节氨酸酸合成酶1 (ASS1) 表达中的作用.
开发一种结合治疗方法,包括MYC向和免疫治疗.

主要成果:

确定了MYC驱动的瘤免疫逃避的新机制.
证明了MYC在调节ASS1表达中的潜在作用,影响了阿金生物合成.
提出了联合MYC向治疗和免疫治疗的理由.

结论:

MYC通过各种途径在瘤免疫逃避中发挥重要作用,包括潜在调节ASS1.1.
针对MYC与免疫治疗一起提供了一个有前途的治疗策略.
调节MYC相互作用蛋白质为组合疗法的临床应用提供了可行的替代方案.

关键词:

我的世界 MYC 综合疗法综合疗法免疫系统逃脱,逃离免疫系统.

更多相关视频

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

相关概念视频

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...